Posted by Michael Wonder on 28 Dec 2018
Rare lung cancer medication made available on the PBS
28 December 2018 - The Liberal National Government will make a medicine for a rare type of lung cancer caused by a gene defect affordable, saving patients $140,000 a year.
From 1 January the medicine Xalkori (crizotinib) will made available through the Pharmaceutical Benefits Scheme for lung cancer patients with a c-ROS proto-oncogene 1 (ROS1) gene rearrangement.
The drug may stop or slow the growth of Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer.
